When the Brain Remembers But the Patient Doesn’t
Unconscious brain activity demonstrated in a case of prosopagnosia
Milan, Italy, July 14, 2011 – Brain damage can cause significant changes in behaviour, such as loss of cognitive skills, but also reveals much about how the nervous system deals with consciousness. New findings reported in the July 2011 issue of Elsevier’sCortex demonstrate how the unconscious brain continues to process information even when the conscious brain is incapacitated.
Dr Stéphane Simon and collaborators in Professor Alan Pegna’s laboratory at Geneva University Hospital, studied a patient brain damaged in an accident who had developed prosopagnosia, or face blindness. They measured her non-conscious responses to familiar faces, using different physiological measures of brain activity, including fMRI and EEG. The patient was shown photographs of unknown and famous people, some of whom were famous before the onset of her prosopagnosia (and others who had become famous more recently). Despite the fact that the patient could not recognize any of the famous faces, her brain activity responded to the faces that she would have recognized before the onset of her condition.
“The results of this study demonstrate that implicit processing might continue to occur despite the presence of an apparent impairment in conscious processing,” says Professor Pegna, “The study has also shed light on what is required for our brain to understand what we see around us. Together with other research findings, this study suggests that the collaboration of several cerebral structures in a specific temporal order is necessary for visual awareness to arise.”
# # #
Notes to Editors
The article is “When the brain remembers, but the patient doesn’t: Converging fMRI and EEG evidence for covert recognition in a case of prosopagnosia” by Stéphane R. Simon, Asaid Khateb, Alexandra Darque, François Lazeyras, Eugene Mayer, and Alan J. Pegna, and appears in Cortex, Volume 47, Issue 7 (July 2010), published by Elsevier in Italy. Full text of the article featured above is available to members of the media upon request. Please contact the Elsevier press office, email@example.com. To schedule an interview, contact Professor Alan Pegna, Alan.Pegna@hcuge.ch.
Cortex is an international journal devoted to the study of cognition and of the relationship between the nervous system and mental processes, particularly as these are reflected in the behaviour of patients with acquired brain lesions, normal volunteers, children with typical and atypical development, and in the activation of brain regions and systems as recorded by functional neuroimaging techniques. It was founded in 1964 by Ennio De Renzi. The Editor in-chief of Cortex is Sergio Della Sala, Professor of Human Cognitive Neuroscience at the University of Edinburgh. Fax: 0131 6513230, e-mail: firstname.lastname@example.org. Cortex is available online at http://www.sciencedirect.com/science/journal/00109452
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.Media contact
+39 02 8818 4353